AMIX

Autonomix Medical, Inc. (AMIX) ESG Analysis Analysis (2026)

Invetso Score: 5.4/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.0 (Moderate)

No disclosed R&D intensity or capital-allocation environmental metrics are provided, limiting evidence that AMIX manages transition-related environmental exposure better than peers.

Zero reported debt-to-equity and low net debt to EBITDA suggest a lighter balance-sheet burden, but this is not an environmental differentiator versus peers.

The absence of reported gross margin and free-cash-flow data prevents assessment of whether operational efficiency supports lower resource intensity than comparable companies.

With no filing-based emissions, energy, or waste disclosures supplied, AMIX cannot be shown to outperform peers on core environmental risk management.

Social

Score:

No workforce, safety, or human-capital disclosure is provided, so AMIX cannot be compared favorably with peers on employee management or retention practices.

Zero stock-based compensation to revenue indicates limited dilution-related stakeholder burden, but this is not enough to establish stronger social positioning than peers.

The lack of disclosed R&D spending limits visibility into product stewardship and customer-impact practices relative to more transparent peers.

Overall social positioning appears neutral because the available metrics do not show either a clear labor-practice advantage or a material social controversy versus peers.

Governance

Score:

Zero debt-to-equity suggests conservative capital structure discipline, which can reduce creditor pressure and governance complexity relative to more levered peers.

Net debt to EBITDA of 0.21 indicates modest leverage, supporting financial oversight quality, although peer-relative governance strength remains unproven without board disclosures.

No stock-based compensation burden is reported, which may limit incentive misalignment, but the absence of proxy and board data prevents a stronger governance score.

Governance remains moderate because the available metrics imply restraint, yet they do not demonstrate the board independence, controls, or transparency that would separate AMIX from peers.

Overall Score

Score:

AMIX screens as a moderate ESG performer because the limited disclosed metrics suggest restrained leverage and compensation burden, but peer-relative ESG leadership is not evidenced.

Score Driver: Insufficient ESG Disclosure Prevents AMIX From Demonstrating A Material Advantage Over Peers Across Environmental, Social, And Governance Dimensions.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Autonomix Medical, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →